TB500

So What Does This Actually Mean?

Plain English summary — no PhD required

TB-500 is a synthetic version of a small fragment of a protein your body already produces naturally, called Thymosin Beta-4. This protein is found in virtually every cell in your body and plays a key role in how cells move and organize themselves during repair.

What It Does

TB-500's main job in research models is enabling cells to move. Specifically, it interacts with actin — the internal scaffolding protein that gives cells their shape and allows them to crawl. By regulating actin dynamics, TB-500 appears to help repair cells migrate from where they're stored to where they're needed. Imagine a city after a storm: TB-500 is studied for its potential role in clearing the roads so repair crews can actually reach the damage.

Why It Matters

Many tissues fail to heal properly not because the body lacks repair cells, but because those cells can't efficiently navigate to the injury site. TB-500's actin-regulating mechanism is particularly interesting to researchers because it works systemically — meaning it may influence cell movement throughout the body, not just at a specific local site. This distinguishes it from more locally-acting compounds like BPC-157.

The Bottom Line

TB-500 has a stronger clinical research foundation than most peptides in this category — its parent molecule (full-length Thymosin Beta-4) entered human trials for wound healing and dry eye. TB-500 itself is a shorter, more targeted fragment. All current TB-500 research is preclinical; it is a research compound only.

Overview

What is TB-500?

TB-500 (also referenced in research literature as TB500, tb-500 peptide, or Thymosin Beta-4 fragment) is a synthetic heptapeptide corresponding to the N-acetylated active fragment (amino acids 17–23) of thymosin beta-4 (Tβ4), a naturally occurring 43-amino-acid protein found ubiquitously in human and animal tissues. Thymosin beta-4 was first isolated from thymic tissue in the 1960s and has since been recognized as a master regulator of actin dynamics — the cytoskeletal processes that govern cell shape, movement, and division.

The TB-500 fragment (Ac-LKKTETQ) retains the actin-binding domain of the full-length thymosin beta-4 molecule, which is responsible for the peptide's primary biological activities in preclinical research models.

Key Takeaways

• TB-500 is the synthetic fragment (Ac-LKKTETQ) of Thymosin Beta-4, a naturally occurring 43-amino-acid protein found in virtually all human and animal cells

• Primary mechanism: regulates actin dynamics (G-actin sequestration), enabling repair cells to migrate efficiently from storage sites to injury locations

• Works systemically — unlike locally-acting compounds, TB-500 may influence cell migration throughout the body, making it particularly studied for widespread or multi-site tissue repair

• Parent molecule (full-length Thymosin Beta-4) has entered human clinical trials for wound healing and dry eye disease, providing a stronger translational foundation than most research peptides

• Research-only compound; all TB-500-specific data is preclinical (animal models); not approved for human use

Composition

Molecular Composition

Amino Acid Sequence

Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln

TB-500 consists of seven amino acids: Leucine-Lysine-Lysine-Threonine-Glutamate-Threonine-Glutamine, with an N-terminal acetyl group (Ac-LKKTETQ). This acetylation is functionally significant — it protects the peptide from aminopeptidase degradation and is required for full actin-sequestering activity.

The compound has a molecular weight of approximately 887.0 Daltons. Despite its reduced size compared to the full thymosin beta-4 molecule, TB-500 retains the critical WH2 (Wiskott-Homology 2) actin-binding motif, which is the structural basis for its primary mechanism of action.

Mechanism of Action

How Does It Work?

!

TB-500 promotes healing by sequestering actin monomers to regulate cell migration and stimulate new blood vessel growth at injury sites.

The central mechanism of TB-500 revolves around its capacity to bind monomeric G-actin (globular actin) and thereby regulate the equilibrium between G-actin and filamentous F-actin. Actin dynamics are essential for virtually every aspect of cell motility, including the directed migration of repair cells to sites of tissue injury.

By sequestering G-actin, TB-500 reduces the pool available for F-actin polymerization in a spatially controlled manner, effectively enabling cells to extend lamellipodia and migrate toward chemotactic gradients. This mechanism is particularly relevant to wound healing, where fibroblasts, endothelial cells, and keratinocytes must migrate into the wound bed to initiate repair.

Beyond actin regulation, preclinical research has identified additional activities of TB-500, including promotion of endothelial cell differentiation and angiogenesis, inhibition of inflammatory cytokine expression (notably IL-1β and TNF-α), and activation of the Akt survival signaling pathway, which confers cytoprotective effects in ischemic tissue models.